Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001386795.1(DTNA):āc.148T>Gā(p.Leu50Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,330 control chromosomes in the GnomAD database, with no homozygous occurrence. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
DTNA (HGNC:3057): (dystrobrevin alpha) The protein encoded by this gene belongs to the dystrobrevin subfamily of the dystrophin family. This protein is a component of the dystrophin-associated protein complex (DPC), which consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and alpha- and beta-dystrobrevin. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Mutations in this gene are associated with left ventricular noncompaction with congenital heart defects. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Uncertain significance, criteria provided, single submitter
clinical testing
Labcorp Genetics (formerly Invitae), Labcorp
Jun 20, 2019
This sequence change replaces leucine with valine at codon 50 of the DTNA protein (p.Leu50Val). The leucine residue is moderately conserved and there is a small physicochemical difference between leucine and valine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a DTNA-related disease. In summary, this variant is a novel missense change that is not predicted to affect protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. -
Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);.;Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);Gain of methylation at K47 (P = 0.0673);